Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$34.26

-2.46 (-6.70%)

, UNH

UnitedHealth

$160.54

2.22 (1.40%)

12:36
12/01/16
12/01
12:36
12/01/16
12:36

Sarepta DMD drug still likely to be covered by UnitedHealth, says RBC Capital

RBC Capital analyst Simos Simeonidis said some language in UnitedHealthcare's (UNH) Commercial Drug Policy for Sarepta's (SRPT) Exondys 51 may have "spooked" investors, but he continues to believe that the DMD drug will end up being covered by the insurer. The analyst, who would be a buyer of Sarepta amid this weakness, keeps an Outperform rating on the stock.

SRPT

Sarepta

$34.26

-2.46 (-6.70%)

UNH

UnitedHealth

$160.54

2.22 (1.40%)

SRPT Sarepta
$34.26

-2.46 (-6.70%)

10/27/16
FBCO
10/27/16
NO CHANGE
Target $68
FBCO
Outperform
Sarepta reimbursement concerns overdone, says Credit Suisse
Credit Suisse analyst Alethia Young believes Sarepta Exondys 51 reimbursement concerns are "quite overdone" and notes payer negotiation is inline with what the company has seen in other rare disease drugs launch. Young rates Sarepta an Outperform with a $68 price target.
10/27/16
WEDB
10/27/16
NO CHANGE
Target $72
WEDB
Outperform
Sarepta selloff overdone, says Wedbush
Wedbush analyst Heather Behanna said the selloff in Sarepta is overdone and recommends shares ahead of the Exondys 51 launch update in January. The analyst has an Outperform rating and a $72 price target on Sarepta shares.
11/11/16
LEER
11/11/16
NO CHANGE
Target $55
LEER
Market Perform
Sarepta Exondys 51 launch expectations seem too high for 2017, says Leerink
Leerink analyst Joseph Schwartz believes Sarepta Exondys 51 launch expectations may be too high for 2017. While nothing that a true Duchenne muscular dystrophy prevalence remains unknown, the analyst says that a "start form" number of about 200 patients would need to be provided in early January in order for investors to be confident in 2017 consensus sales estimates of $215M. Additionally, Schwartz points out that based on the price of Exondys 51 per vial, it currently appears that management has underestimated the true price of the drug which they will realize.
11/29/16
BARD
11/29/16
NO CHANGE
Target $102
BARD
Outperform
Baird sees strong launch for Sarepta after surveying neurologists
After his firm surveyed 30 neurologists treating at least ten Duchenne muscular dystrophy patients and at least five suspected/confirmed patients amenable to exon-51 skipping, Baird analyst Brian Skorney believes Sarepta Therapeutics' Exondys 51 is positioned for a strong launch. In a research note earlier today, Skorney said that most of the 30 doctors surveyed seem convinced of the drug's efficacy, and plan to start prescribing the drug in the next year. The drug's consensus sales estimate for its first quarter on the market of $7.1M may be understating sales, Skorney wrote. The analyst continues to expect $11M of Exondys 51 sales in Q4. He has an Outperform rating on shares of Sarepta with a $102 price target. The stock is up 34c, or 1%, to $36.62 in morning trading.
UNH UnitedHealth
$160.54

2.22 (1.40%)

11/30/16
OPCO
11/30/16
NO CHANGE
Target $171
OPCO
Outperform
UnitedHealth price target raised to $171 from $161 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for UnitedHealth to $171 from $161 on "strong" 2017 outlook buoyed by robust Medicare Advantage growth. The analyst believes the business is performing well, and could benefit from the changes in Washington given the GOP bias toward managed care. Wiederhorn reiterates an Outperform rating on the shares and says he would continue to be a buyer of the blue-chip name.
11/30/16
UBSW
11/30/16
NO CHANGE
Target $193
UBSW
Buy
UnitedHealth price target raised to $193 from $180 at UBS
UBS analyst A.J. Rice raised his price target on UnitedHealth to $193 from $180 following its very positive investor day. The company said they see strong growth driven by both group and individual markets while controlling their commercial medical cost trend, noted Rice, who reiterated his Buy rating on UnitedHealth shares.
11/30/16
COWN
11/30/16
NO CHANGE
Target $175
COWN
Outperform
UnitedHealth price target raised to $175 from $150 at Cowen
Cowen analyst Christine Arnold raised her price target on UnitedHealth to $175 from $150 reflecting the company's guidance provided at its analyst day.The analyst said UnitedHealth remains a top pick for 2017 as it has an abundance of tailwinds and minimal company-specific headwinds. Arnold reiterated her Outperform rating on UnitedHealth shares.
11/30/16
SBSH
11/30/16
NO CHANGE
Target $178
SBSH
Buy
UnitedHealth price target raised to $178 after analyst day at Citi
Citi analyst Ralph Giacobbe said UnitedHealth's "upbeat tone" at its investor day matched the company's "impressive" 2017 guidance, saying the company remains in an enviable position of having size, scale, and infrastructure to invest while expanding its reach via Optum. Giacobbe raised his price target on UnitedHealth shares to $178 from $164 and keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

KFRC

Kforce

$25.50

0.3 (1.19%)

05:15
02/24/17
02/24
05:15
02/24/17
05:15
Downgrade
Kforce rating change  »

Kforce downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTU

Intuit

$120.70

1.27 (1.06%)

05:14
02/24/17
02/24
05:14
02/24/17
05:14
Upgrade
Intuit rating change  »

Intuit upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$24.66

-0.12 (-0.48%)

05:13
02/24/17
02/24
05:13
02/24/17
05:13
Downgrade
HP Enterprise rating change  »

HP Enterprise downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$38.58

-2.68 (-6.50%)

05:13
02/24/17
02/24
05:13
02/24/17
05:13
Downgrade
Wayfair rating change  »

Wayfair downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTGC

Hercules Capital

$14.94

-0.49 (-3.18%)

05:12
02/24/17
02/24
05:12
02/24/17
05:12
Downgrade
Hercules Capital rating change  »

Hercules Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IVR

Invesco Mortgage

$15.57

0.08 (0.52%)

05:12
02/24/17
02/24
05:12
02/24/17
05:12
Downgrade
Invesco Mortgage rating change  »

Invesco Mortgage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

REG

Regency Centers

$70.95

0.94 (1.34%)

, EQY

Equity One

$31.91

0.39 (1.24%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Equity One to host special shareholder meeting »

Special Shareholder…

REG

Regency Centers

$70.95

0.94 (1.34%)

EQY

Equity One

$31.91

0.39 (1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

MMM

3M

$187.19

1.15 (0.62%)

, BIOL

BIOLASE

$1.50

-0.02 (-1.32%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Chicago Dental Society to hold a meeting »

Chicago Dental Midwinter…

MMM

3M

$187.19

1.15 (0.62%)

BIOL

BIOLASE

$1.50

-0.02 (-1.32%)

COF

Capital One

$93.41

0.52 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIO

Rio Tinto

$42.51

-1.83 (-4.13%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Rio Tinto management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 26

    Feb

EQY

Equity One

$31.91

0.39 (1.24%)

, REG

Regency Centers

$70.95

0.94 (1.34%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Regency Centers to host special shareholder meeting »

Special Shareholder…

EQY

Equity One

$31.91

0.39 (1.24%)

REG

Regency Centers

$70.95

0.94 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

CASM

CAS Medical

$1.48

-0.01 (-0.67%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
CAS Medical management to meet with Craig Hallum »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

PBNC

Paragon Commercial

$50.50

-0.35 (-0.69%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Paragon Commercial management to meet with Sandler O'Neill »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

SC

Santander Consumer

$14.33

-0.12 (-0.83%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Santander Consumer management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

ELNK

EarthLink

$5.85

0.04 (0.69%)

, WIN

Windstream

$7.29

0.07 (0.97%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Windstream to host special shareholder meeting »

Virtual Special…

ELNK

EarthLink

$5.85

0.04 (0.69%)

WIN

Windstream

$7.29

0.07 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 01

    Mar

  • 06

    Mar

GIS

General Mills

$60.78

0.19 (0.31%)

, TSN

Tyson Foods

$62.82

-0.4 (-0.63%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
The Consumer Analyst Group of New York to hold a conference »

2017 CAGNY Conference is…

GIS

General Mills

$60.78

0.19 (0.31%)

TSN

Tyson Foods

$62.82

-0.4 (-0.63%)

TWNK

Hostess Brands

$15.78

0.31 (2.00%)

MJN

Mead Johnson

$87.61

0.11 (0.13%)

K

Kellogg

$74.80

0.31 (0.42%)

MDLZ

Mondelez

$44.89

0.24 (0.54%)

INGR

Ingredion

$122.28

1.66 (1.38%)

LNCE

Snyder's-Lance

$39.60

0.17 (0.43%)

SYY

Sysco

$52.89

0.14 (0.27%)

JNJ

Johnson & Johnson

$120.90

2.18 (1.84%)

SJM

J.M. Smucker

$140.83

0.1 (0.07%)

MO

Altria Group

$74.46

0.86 (1.17%)

CPB

Campbell Soup

$59.06

-0.11 (-0.19%)

PEP

PepsiCo

$109.54

0.13 (0.12%)

CLX

Clorox

$135.83

-0.09 (-0.07%)

BG

Bunge

$80.05

0.61 (0.77%)

PG

Procter & Gamble

$91.13

-0.31 (-0.34%)

DANOY

Danone

$13.34

0.13 (0.98%)

SPB

Spectrum Brands

$137.26

0.97 (0.71%)

KO

Coca-Cola

$41.66

0.06 (0.14%)

IFF

International Flavors

$125.14

2.51 (2.05%)

STZ

Constellation Brands

$153.60

-6.6 (-4.12%)

NSRGY

Nestle

$74.20

0.4 (0.54%)

CHD

Church & Dwight

$49.62

-0.07 (-0.14%)

UN

Unilever; also tag UL

$46.58

-0.17 (-0.36%)

CL

Colgate-Palmolive

$74.44

0.95 (1.29%)

NWL

Newell Brands

$46.80

-0.26 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 27

    Feb

  • 09

    Mar

  • 14

    Mar

  • 15

    Mar

  • 19

    Mar

  • 27

    Mar

  • 09

    May

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
CLSA to hold a forum »

Japan Forum is being held…

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
CLSA financial tech analyst holds an analyst/industry conference call »

Financial Technology…

AGN

Allergan

$246.33

0.71 (0.29%)

, EDGE

Edge Therapeutics

$10.00

-0.27 (-2.63%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
American Heart Association to hold a conference »

International Stroke…

AGN

Allergan

$246.33

0.71 (0.29%)

EDGE

Edge Therapeutics

$10.00

-0.27 (-2.63%)

AMGN

Amgen

$174.01

1.4 (0.81%)

ATRC

AtriCure

$17.35

0.13 (0.75%)

BMY

Bristol-Myers

$55.77

0.42 (0.76%)

DNA

Bought by RHHBY

MDCO

The Medicines Co.

$51.84

-0.38 (-0.73%)

MDT

Medtronic

$80.74

1.12 (1.41%)

MRK

Merck

$65.85

0.56 (0.86%)

PH

Parker-Hannifin

$153.70

-2.16 (-1.39%)

PTLA

Portola Pharmaceuticals

$32.16

0.02 (0.06%)

Q

QuintilesIMS

$78.12

0.77 (1.00%)

SSNLF

Samsung

SAY

Satyam

TWTR

Twitter

$16.03

-0.05 (-0.31%)

WTKWY

Wolters Kluwer

$40.39

0.502 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 02

    Mar

  • 07

    Mar

  • 08

    Mar

  • 09

    Mar

  • 15

    Mar

  • 17

    Mar

  • 19

    Mar

  • 21

    Mar

  • 28

    Mar

  • 01

    Apr

  • 04

    May

  • 10

    May

  • 27

    May

  • 14

    Jun

  • 24

    Jun

  • 19

    Jul

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Wells Fargo housing analyst holds an analyst/industry conference call »

Senior Housing Analyst…

NVO

Novo Nordisk

$35.78

0.53 (1.50%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Novo Nordisk management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 07

    Mar

KAR

KAR Auction

$44.50

-0.3 (-0.67%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
KAR Auction management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 13

    Mar

  • 14

    Mar

  • 15

    Mar

04:55
02/24/17
02/24
04:55
02/24/17
04:55
General news
Consumer Sentiment Index to be reported at 10:00 »

February Consumer…

04:55
02/24/17
02/24
04:55
02/24/17
04:55
General news
New Home Sales to be reported at 10:00 »

January New Home Sales…

VWDRY

Vestas

$25.08

0.175 (0.70%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Vestas management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

HSIC

Henry Schein

$171.92

-0.72 (-0.42%)

04:55
02/24/17
02/24
04:55
02/24/17
04:55
Conference/Events
Henry Schein management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.